Bioceres Crop Solutions Corp.
BIOX | NASDAQ
$0.45
$0.00 (-0.22%)
Nov 2, 2026, 12:00 PM ET · Market open
Market Data
Market Cap $28.52M
Enterprise Value $255.39M
Beta 0.46
Average Volume 931.44K
Shares Outstanding (Diluted) 63.48M
Shares Change YoY 0.44%
Institutional Ownership 21.58%
Exchange NASDAQ
ISIN KYG1117K1141
Price Performance
Price Change 1M -18.0%
Price Change 3M -28.2%
Price Change 6M -73.6%
Price Change YTD -66.6%
Price Change 1Y -90.3%
Price Change 3Y -96.1%
Price Change 5Y -97.0%
1M CAGR (ann.) 38.9%
1Y CAGR (ann.) -87.8%
5Y CAGR (ann.) -48.5%
All-Time CAGR -29.7%
Valuation
PE Ratio -0.12
Forward PE 9.93
PEG Ratio 0.00
Forward PEG N/A
PS Ratio 0.10
Forward PS 0.10
PB Ratio 0.39
P/FCF Ratio 0.40
P/Adj. FCF Ratio 0.41
P/OCF Ratio 0.37
EV/Sales 0.90
EV/EBIT -47.90
EV/EBITDA 21.14
EV/FCF 3.56
Earnings Yield -826.7%
FCF Yield 251.7%
Adj. FCF Yield 244.5%
Financial Health
Net Debt $215.99M
Total Debt $239.46M
Cash & Short-Term Investments $12.58M
Total Assets $560.36M
Current Ratio 0.90
Quick Ratio 0.69
Debt / Equity Ratio 3.25
Debt / EBITDA 19.82
Debt / FCF 3.34
OCF / Debt 0.33
Interest Coverage 0.01
Altman Z-Score -0.19
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 37.1%
Operating Profit Margin 0.2%
EBITDA Margin 4.2%
Net Profit Margin -82.8%
FCF Margin 25.2%
Adj. FCF Margin 24.4%
SBC / Revenue 0.7%
SBC Impact (per share) -2.9%
Returns
Return on Assets -42.1%
Return on Equity -105.5%
Return on Invested Capital 0.1%
Return on Capital Employed 0.3%
Return on Tangible Assets -54.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 0.5%
Revenue CAGR 5Y 14.1%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -127.5%
EPS CAGR 5Y -197.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y 77.7%
FCF CAGR 5Y 48.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y 40.7%
Revenue Growth Next 3Y 26.6%
Earnings Date Sep 8, 2026
EPS Estimate (next Q) -$0.06
EPS Growth Est (next Q) N/A
Revenue Est (next Q) $79M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $2.00
Price Target Upside 344.4%
Cash Flow
Operating Cash Flow $78.02M
Free Cash Flow $71.76M
Adj. Free Cash Flow $69.72M
FCF Per Share $1.13
OCF Per Share $1.23
OCF/S Ratio 27.4%
Income Statement
Revenue $285.11M
Gross Profit $105.7M
Operating Income $663.87K
EBITDA $12.08M
Net Income $-235.97M
EPS (Diluted) -$3.72
Revenue / Employee $712.77K
Profit / Employee $-589.93K
Employees 400
Add to Watchlist
Select watchlists to add or remove BIOX